NO20055880L - Memantin orale doseringsformer - Google Patents

Memantin orale doseringsformer

Info

Publication number: NO20055880L
Authority: NO; Norway
Prior art keywords: memantine; dosage form; dosage forms; oral dosage; memantine oral
Prior art date: 2003-06-16

Application number

NO20055880A

Other languages

English (en)

Norwegian (no)

Inventor

Bruce A Firestone

John J Vander Zanden

Janet K Cheetham

Richard Kurjan

Teresa H Kuan

Ching-Ming Chang

J Abraham M Espiritu

Original Assignee

Allergan Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-16

Filing date

2005-12-12

Publication date

2005-12-28

2005-12-12 Application filed by Allergan Inc filed Critical Allergan Inc

2005-12-28 Publication of NO20055880L publication Critical patent/NO20055880L/no

Links

BUGYDGFZZOZRHP-UHFFFAOYSA-N memantine Chemical compound C1C(C2)CC3(C)CC1(C)CC2(N)C3 BUGYDGFZZOZRHP-UHFFFAOYSA-N 0.000 title abstract 6
229960004640 memantine Drugs 0.000 title abstract 6
239000006186 oral dosage form Substances 0.000 title abstract 2
239000002552 dosage form Substances 0.000 abstract 5
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
229940127557 pharmaceutical product Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Ophthalmology & Optometry (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20055880A 2003-06-16 2005-12-12 Memantin orale doseringsformer NO20055880L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US47897903P	2003-06-16	2003-06-16
PCT/US2004/018506 WO2004112768A1 (en)	2003-06-16	2004-06-10	Memantine oral dosage forms

Publications (1)

Publication Number	Publication Date
NO20055880L true NO20055880L (no)	2005-12-28

Family

ID=33539133

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20055880A NO20055880L (no)	2003-06-16	2005-12-12	Memantin orale doseringsformer

Country Status (16)

Country	Link
US (2)	US20040254251A1 (pt)
EP (1)	EP1631273A1 (pt)
JP (1)	JP2006527774A (pt)
KR (1)	KR20060033727A (pt)
CN (1)	CN1805737A (pt)
AU (1)	AU2004249151A1 (pt)
BR (1)	BRPI0411451A (pt)
CA (1)	CA2529535A1 (pt)
IL (1)	IL172233A0 (pt)
MX (1)	MXPA05012810A (pt)
NO (1)	NO20055880L (pt)
PL (1)	PL378902A1 (pt)
RU (1)	RU2006101225A (pt)
TW (1)	TW200524639A (pt)
WO (1)	WO2004112768A1 (pt)
ZA (1)	ZA200509379B (pt)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7086532B2 (en) *	2003-07-16	2006-08-08	Allergan, Inc.	Titration/compliance pack with increasing doses
FR2855344A1 (fr) *	2003-05-22	2004-11-26	France Telecom	Systeme de gestion de contexte pour un reseau comportant un ensemble heterogene de terminaux
BRPI0512263A (pt) *	2004-06-17	2008-02-26	Merz Pharma Gmbh & Co Kgaa	formulações de liberação imediata de formas de dosagem oral de memantina
US20060002999A1 (en) *	2004-06-17	2006-01-05	Forest Laboratories, Inc.	Immediate release formulations of 1-aminocyclohexane compounds, memantine and neramexane
US7619007B2 (en)	2004-11-23	2009-11-17	Adamas Pharmaceuticals, Inc.	Method and composition for administering an NMDA receptor antagonist to a subject
AU2005309601A1 (en) *	2004-11-23	2006-06-01	Neuromolecular Pharmaceuticals, Inc.	Composition comprising a sustained release coating or matrix and an NMDA receptor antagonist, method for administration such NMDA antagonist to a subject
US8058291B2 (en)	2005-04-06	2011-11-15	Adamas Pharmaceuticals, Inc.	Methods and compositions for the treatment of CNS-related conditions
US20060159753A1 (en) *	2004-12-27	2006-07-20	Eisai Co. Ltd.	Matrix type sustained-release preparation containing basic drug or salt thereof
US20060160852A1 (en) *	2004-12-27	2006-07-20	Eisai Co. Ltd.	Composition containing anti-dementia drug
CA2592605C (en)	2004-12-27	2010-12-07	Eisai R&D Management Co., Ltd.	Method for stabilizing anti-dementia drug
CA2604617C (en) *	2005-04-28	2014-06-17	Eisai R&D Management Co., Ltd.	Composition containing anti-dementia drug
DE602007003697D1 (de) *	2006-02-10	2010-01-21	Janssen Pharmaceutica Nv	Ffner
AU2007241809A1 (en) *	2006-04-20	2007-11-01	Itoham Foods Inc.	Pharmaceutical composition for conformational disease
CN101528202A (zh) *	2006-07-05	2009-09-09	特瓦制药工业有限公司	美金刚的药物组合物
EP1908748A1 (en) *	2006-10-05	2008-04-09	Krka	Process for the preparation of memantine and its hydrochloric acid salt form
EP2420235A1 (en) *	2006-10-27	2012-02-22	Medivation Neurology, Inc.	Methods and combination therapies for treating alzheimer's disease
US20080182908A1 (en) *	2007-01-25	2008-07-31	Vinita Umashankar Vyas	Pharmaceutical compositions comprising memantine
EP2170310A4 (en) *	2007-06-29	2010-06-23	Orchid Chemicals & Pharm Ltd	FAST-DISSOLVING COMPOSITIONS OF MEMANTINE HYDROCHLORIDE
EP2583669A1 (en)	2007-10-10	2013-04-24	Rubicon Research Private Limited	Taste-masked orally disintegrating tablets of memantine hydrochloride
WO2009091932A2 (en) *	2008-01-18	2009-07-23	Adamas Pharmaceuticals, Inc.	Treatment of mild dementia of the alzheimer's disease type
US20090247644A1 (en) *	2008-03-28	2009-10-01	Forest Laboratories Holdings Limited	Memantine formulations
JP5885668B2 (ja)	2009-12-02	2016-03-15	アダマスファーマシューティカルズ，インコーポレイテッド	アマンタジン組成物および使用方法
IN2014MN02029A (pt) *	2012-04-24	2015-08-14	Daiichi Sankyo Companyltd
WO2014204933A1 (en)	2013-06-17	2014-12-24	Adamas Pharmaceuticals, Inc.	Amantadine compositions and methods of use
KR20190076711A (ko)	2017-12-22	2019-07-02	한미약품 주식회사	메만틴을 포함하는 속방성 및 서방성을 동시에 가지는 경질캡슐 제제 및 그 제조방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2856393C2 (de) *	1978-12-27	1983-04-28	Merz + Co GmbH & Co, 6000 Frankfurt	Arzneimittel zur Behandlung von Morbus Parkinson
AUPN605795A0 (en) *	1995-10-19	1995-11-09	F.H. Faulding & Co. Limited	Analgesic pharmaceutical composition
US6057373A (en) *	1997-05-22	2000-05-02	Synchroneuron, Llc	Methods of treating tardive dyskinesia and other movement disorders using NMDA receptor antagonists
US6849271B2 (en) *	2001-04-27	2005-02-01	Verion, Inc.	Microcapsule matrix microspheres, absorption-enhancing pharmaceutical compositions and methods

2004
- 2004-06-10 BR BRPI0411451-5A patent/BRPI0411451A/pt not_active IP Right Cessation
- 2004-06-10 WO PCT/US2004/018506 patent/WO2004112768A1/en not_active Ceased
- 2004-06-10 PL PL378902A patent/PL378902A1/pl not_active Application Discontinuation
- 2004-06-10 AU AU2004249151A patent/AU2004249151A1/en not_active Abandoned
- 2004-06-10 CN CNA2004800167729A patent/CN1805737A/zh active Pending
- 2004-06-10 JP JP2006517215A patent/JP2006527774A/ja active Pending
- 2004-06-10 CA CA002529535A patent/CA2529535A1/en not_active Abandoned
- 2004-06-10 EP EP04754939A patent/EP1631273A1/en not_active Withdrawn
- 2004-06-10 KR KR1020057024218A patent/KR20060033727A/ko not_active Withdrawn
- 2004-06-10 RU RU2006101225/15A patent/RU2006101225A/ru not_active Application Discontinuation
- 2004-06-10 MX MXPA05012810A patent/MXPA05012810A/es not_active Application Discontinuation
- 2004-06-15 US US10/869,169 patent/US20040254251A1/en not_active Abandoned
- 2004-06-16 TW TW093117335A patent/TW200524639A/zh unknown
2005
- 2005-11-17 ZA ZA200509379A patent/ZA200509379B/xx unknown
- 2005-11-28 IL IL172233A patent/IL172233A0/en unknown
- 2005-12-12 NO NO20055880A patent/NO20055880L/no not_active Application Discontinuation
2006
- 2006-07-13 US US11/457,182 patent/US20060251717A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2529535A1 (en)	2004-12-29
US20040254251A1 (en)	2004-12-16
RU2006101225A (ru)	2006-06-10
AU2004249151A1 (en)	2004-12-29
BRPI0411451A (pt)	2006-07-18
CN1805737A (zh)	2006-07-19
PL378902A1 (pl)	2006-05-29
IL172233A0 (en)	2006-04-10
ZA200509379B (en)	2006-11-29
EP1631273A1 (en)	2006-03-08
US20060251717A1 (en)	2006-11-09
KR20060033727A (ko)	2006-04-19
MXPA05012810A (es)	2006-02-13
TW200524639A (en)	2005-08-01
JP2006527774A (ja)	2006-12-07
WO2004112768A1 (en)	2004-12-29

Similar Documents

Publication	Publication Date	Title
MXPA05012810A (es)	2006-02-13	Formas de dosis oral de memantina.
WO2005065069A3 (en)	2005-09-22	Pharmaceutical methods, dosing regimes and dosage forms for the treatment of alzheimer's disease
RU2010105122A (ru)	2011-10-10	Композиции для ухода за полостью рта, продукты и способы применения
AR050418A1 (es)	2006-10-25	Dosificacion fija de anticuerpos her
BRPI0513200A (pt)	2008-04-29	uso de um anticorpo anti-igf-1r na preparação de um medicamento para tratamento combinado para malignidades não-hematológicas
ES2153338T1 (es)	2001-03-01	Dosificacion mejorada de dosis multiples de medicamentos.
PE20040134A1 (es)	2004-03-06	Forma de dosificacion de una vez al dia de pramipexol
ATE298324T1 (de)	2005-07-15	Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
BR9909672A (pt)	2007-07-31	uso de um composto medicinal ativo no preparo de um medicamento para o tratamento de hipertensão
TWI455723B (zh)	2014-10-11	納曲酮及安非他酮於治療超重或肥胖病患之用途
RU2008122358A (ru)	2009-12-10	Лекарственные формы, содержащие ag013736
KR970061244A (ko)	1997-09-12	치매 치료용 약학 조성물
ES2524369T3 (es)	2014-12-05	Unidad de dosificación que incluye un análogo de prostaglandina para el tratamiento del estreñimiento
AR036312A1 (es)	2004-08-25	Composicion farmaceutica
RU2008119454A (ru)	2009-11-27	Лекарственное средство для защиты моторного нейрона у пациентов с боковым амиотрофическим склерозом
KR970025615A (ko)	1997-06-24	암 전이 억제제
ES2175663T3 (es)	2002-11-16	Composiciones farmaceuticas solidas que contienen miltefosina para administracion oral en el tratamiento de la leshmaniasis.
AR026254A1 (es)	2003-02-05	El uso de una preparacion de liberacion controlada para la preparacion de un medicamento para aumentar la dosis o la exposicion sistemica de un farmaco queinhibe la fosfodiesterasa 4
BR0009380A (pt)	2001-12-26	Tratamento de câncer melhorado comtemozolomida
MXPA03003994A (es)	2004-09-10	Composiciones de metformina de liberacion controlada.
KR960028907A (ko)	1996-08-17	암환자를 치료하기 위한 세트랄린의 용도
EA200800075A1 (ru)	2008-04-28	Схема дозирования для празугреля
SE0102887D0 (sv)	2001-08-29	New formulation
AR047154A1 (es)	2006-01-11	Tratamiento del insomnio en pacientes humanos administrandoles una cantidad diaria de gaboxadol
DE60331920D1 (de)	2010-05-12	Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren

Legal Events

Date	Code	Title	Description
2009-02-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application